REPROCELL join Medicines Discovery Catapult’s Virtual R&D network to accelerate drug development
12 March 2019
The collaboration is part of Medicines Discovery Catapult’s Virtual R&D network, which aims to support UK SMEs develop and execute their drug discovery projects with industrial rigour. The collaboration is part of Medicines Discovery Catapu...
REPROCELL Inc. forms joint venture with Fox Chase Cancer Center to begin operations on biosample repositories
28 February 2019
BELTSVILLE, MD. — REPROCELL Inc. and Fox Chase, Ltd., a member of the Fox Chase Cancer Center family of organizations, have formed a joint venture to begin operations of multi-site biosample repository facilities globally. The new Delaware-...
Appointment of New Distributor in China
01 February 2019
The REPROCELL group has signed a non-exclusive distributorship agreement with RUITAI Biotechnology (Shanghai) Ltd to distribute REPROCELL’s products in China. Through the RUITAI group’s offices in Shanghai, Hangzhou, and Shenyang, and combi...
The importance of internships for life science students
19 October 2018
If you are a science student nearing the end of your university program, developing your professional network in order to land a good job is a daunting task. In this video, Zara Puckrin and Karen Bingham talk about Zara's experience interni...
ROSLINCT and REPROCELL awarded £1.2 million from Innovate UK for clinical-grade stem cell production
10 October 2018
Funding will be used to improve efficiency of induced pluripotent stem cell production Edinburgh, UK and Glasgow, UK: ROSLINCT, a leading cell and gene therapy contract manufacturing organisation, today announced it is to receive a £1.2 mil...
REPROCELL announces the launch of a cutting-edge iPS cell genome editing service utilizing next-generation CRISPR/Cas9 technology: SNIPER
09 October 2018
REPROCELL announced today we have launched a cutting-edge genome editing service utilizing next-generation CRISPR/Cas9 technology, called SNIPER. This service is offered in collaboration with GenAhead Bio Inc. (Kanagawa, Japan; hereinafter ...
How paid internships can benefit life science students
13 September 2018
How can industry inspire the next generation of life science professionals? In this post, summer intern Zara Puckrin describes the challenges faced by today’s graduates and explains how REPROCELL have helped her to bridge the gap between un...
Steminent Announces Japan partner REPROCELL has PMDA Approval of CTN for Phase II Trial of Stemchymal® SCA in the Treatment of Spinocerebellar Ataxia in Japan
01 August 2018
San Diego, CA, USA – Steminent Biotherapeutics Inc. (“Steminent” or “Company”) a private, clinical-stage cell-therapy company with offices in Taiwan, San Diego and Shanghai, is pleased to announce that the Clinical Trial Notification (“CTN”...
Human Tissue Experts REPROCELL Launch New Customized Primary Cell Isolation Services
21 June 2018
REPROCELL’s BioServe and Biopta tissue procurement networks combine to create a new service isolating human primary cells. REPROCELL Human Tissue Networks REPROCELL, the leading human tissue research company, is further expanding its range ...
REPROCELL’s footprint extends to serve life sciences in India
13 June 2018
REPROCELL India (formerly BioServe Biotechnologies) is a state-of-the-art biotechnology company with a mission to serve the life sciences research ecosystem. BioServe Biotechnologies (India) has been a pioneer commercial laboratory that beg...